| 000 | 01243 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250514050928.0 | ||
| 264 | 0 | _c20030409 | |
| 008 | 200304s 0 0 eng d | ||
| 022 | _a0312-5963 | ||
| 024 | 7 |
_a10.2165/00003088-200241130-00004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWight, William J | |
| 245 | 0 | 0 |
_aPharmacokinetics and pharmacodynamics of rapacuronium bromide. _h[electronic resource] |
| 260 |
_bClinical pharmacokinetics _c2002 |
||
| 300 |
_a1059-76 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAnesthesia Recovery Period |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntubation, Intratracheal |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xmetabolism |
| 650 | 0 | 4 |
_aLiver Cirrhosis _xmetabolism |
| 650 | 0 | 4 |
_aNeuromuscular Nondepolarizing Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aVecuronium Bromide _xadministration & dosage |
| 700 | 1 | _aWright, Peter M C | |
| 773 | 0 |
_tClinical pharmacokinetics _gvol. 41 _gno. 13 _gp. 1059-76 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00003088-200241130-00004 _zAvailable from publisher's website |
| 999 |
_c12212073 _d12212073 |
||